A Preliminary Candidate Genotype-Intermediate Phenotype Study of Satiation and Gastric Motor Function in Obesity

Obesity

Volumn 18, Issue 6, 2010, Pages 1201-1211

  Papathanasopoulos, Athanasios ^a   Camilleri, Michael ^a   Carlson, Paula J ^a   Vella, Adrian ^a   Nord, Sara J Linker ^a   Burton, Duane D ^a   Odunsi, Suwebatu T ^a   Zinsmeister, Alan R ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADR2C GENE; ADRA2A GENE; ADRB3 GENE; ADULT; AGED; ARTICLE; DIET RESTRICTION; EPIGASTRIC FULLNESS; FEMALE; FTO GENE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GNB3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTPRANDIAL STATE; RECESSIVE INHERITANCE; SATIETY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLC6A4 GENE; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH SCINTISCANNING; STOMACH VOLUME; UCP 2 GENE; UCP 3 GENE; VALIDATION STUDY; ADOLESCENT; BIOLOGICAL MODEL; CLINICAL TRIAL; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; SCINTISCANNING; STOMACH MUCOSA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APPETITE REGULATION; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL MOTILITY; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SATIATION; YOUNG ADULT;

EID: 77952950894     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.360     Document Type: Article

References (42)

1. Ogden CL, Carroll MD, Curtin LR, et al., Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
2. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276: 1907-1915.
3. Blundell JE, Gillett A,. Control of food intake in the obese. Obes Res 2001; 9 Suppl 4: 263S-270S.
4. Hill AJ, Magson LD, Blundell JE,. Hunger and palatability: tracking ratings of subjective experience before, during and after the consumption of preferred and less preferred food. Appetite 1984; 5: 361-371.
5. Woods SC,. Signals that influence food intake and body weight. Physiol Behav 2005; 86: 709-716.
6. Deutsch JA,. The role of the stomach in eating. Am J Clin Nutr 1985; 42: 1040-1043.
7. Deutsch JA, Young WG, Kalogeris TJ,. The stomach signals satiety. Science 1978; 201: 165-167.
8. Roque MI Vazquez, Camilleri M, Stephens DA, et al., Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology 2006; 131: 1717-1724.
9. Delgado-Aros S, Camilleri M, Castillo EJ, et al., Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol 2005; 3: 997-1006.
10. Delgado-Aros S, Camilleri M, Cremonini F, et al., Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685-1694.
11. Delgado-Aros S, Cremonini F, Castillo JE, et al., Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology 2004; 126: 432-440.
12. Huang GH, Hsieh CC, Chen CH, Chen WJ,. Statistical validation of endophenotypes using a surrogate endpoint analytic analogue. Genet Epidemiol 2009; 33: 549-558.
13. Cummings DE, Overduin J,. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117: 13-23.
14. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR,. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999; 116: 573-585.
15. Grudell AB, Camilleri M, Carlson P, et al., An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil 2008; 20: 213-219.
16. Grudell AB, Sweetser S, Camilleri M, et al., A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology 2008; 135: 1142-1154.
17. Roque MI Vazquez, Camilleri M, Clark MM, et al., Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol 2007; 5: 829-837.
18. Wardle J, Carnell S, Haworth CM, et al., Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 2008; 93: 3640-3643.
19. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR,. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002; 16: 1781-1790.
20. Bouras EP, Delgado-Aros S, Camilleri M, et al., SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut 2002; 51: 781-786.
21. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D,. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil 2004; 16: 567-573.
22. Delgado-Aros S BD, Brinkmann BH, Camilleri M,. Reliability of a semi automated analysis to measure gastric accommodation using SPECT in humans. Gastroenterology 2001; 120: A287(abstract).
23. Chial HJ, Camilleri C, Delgado-Aros S, et al., A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil 2002; 14: 249-253.
24. Hofker M, Wijmenga C,. A supersized list of obesity genes. Nat Genet 2009; 41: 139-140.
25. Evans BA, Papaioannou M, Bonazzi VR, Summers RJ,. Expression of beta 3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 1996; 117: 210-216.
26. Kurokawa N, Young EH, Oka Y, et al., The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond) 2008; 32: 1240-1249.
27. Meyre D, Delplanque J, Chèvre JC, et al., Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009; 41: 157-159.
28. Wardle J, Llewellyn C, Sanderson S, Plomin R,. The FTO gene and measured food intake in children. Int J Obes (Lond) 2009; 33: 42-45.
29. Fleury C, Neverova M, Collins S, et al., Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997; 15: 269-272.
30. Evans D, Minouchehr S, Hagemann G, et al., Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes Relat Metab Disord 2000; 24: 1239-1245.
31. Jun HS, Kim IK, Lee HJ, et al., Effects of UCP2 and UCP3 variants on the manifestation of overweight in Korean children. Obesity (Silver Spring) 2009; 17: 355-362.
32. van Abeelen AF, de Krom M, Hendriks J, et al., Variations in the uncoupling protein-3 gene are associated with specific obesity phenotypes. Eur J Endocrinol 2008; 158: 669-676.
33. Tack J, Depoortere I, Bisschops R, et al., Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-333.
34. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
35. Walder K, Norman RA, Hanson RL, et al., Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet 1998; 7: 1431-1435.
36. Lima JJ, Feng H, Duckworth L, et al., Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metab Clin Exp 2007; 56: 757-765.
37. Hunt SC, Stone S, Xin Y, et al., Association of the FTO gene with BMI. Obesity (Silver Spring) 2008; 16: 902-904.
38. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN,. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 2008; 359: 2558-2566.
39. Siffert W, Forster P, Jöckel KH, et al., Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999; 10: 1921-1930.
40. Sookoian S, Gemma C, García SI, et al., Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007; 15: 271-276.
41. Sookoian S, Gianotti TF, Gemma C, Burgueño A, Pirola CJ,. Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) 2008; 16: 488-491.
42. Fuemmeler BF, Agurs-Collins TD, McClernon FJ, et al., Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring) 2008; 16: 348-355.